Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination
Clinical trial NCT02475135 · COMPLETED
Trial details
- NCT number
- NCT02475135
- Sponsor
- Janssen Sciences Ireland UC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2015-08-14
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.